Karuna, hoping to find new brain drugs, buys up a shuttering biotech’s pipeline
Bio Pharma Dive
FEBRUARY 2, 2023
Though Goldfinch Bio focused on kidney diseases, Karuna believes its experimental drugs may have potential treating psychiatric and neurological conditions
Let's personalize your content